http://www.fpnotebook.com/
Antenatal ScreeningAka: Prenatal Diagnosis
- Protocol: First Trimester Screening
- Combination screening recommended
- Pregnancy-Associated Plasma Protein A (PAPP-A) and
- Nuchal Translucency (performed at 11 to 13 weeks)
- Efficacy
- Detecting Trisomy 21 (Down Syndrome) in all women
- Test Sensitivity: 78-89% (>90% if age over 35 years)
- Test Specificity: 95% (only 78-86% if age over 35 years)
- Detecting Trisomy 18
- Test Sensitivity: 90%
- Test Specificity: 98%
- Detecting Trisomy 21 (Down Syndrome) in all women
- Additional findings
- Low levels of both markers are associated with adverse pregnancy outcomes
- Combination screening recommended
- Protocol: Second Trimester Screening
- Combination screening
- Serum testing (Quad Screen) and
- Second Trimester Ultrasound
- Efficacy: Amniocentesis with Quad Screen
- Test Sensitivity: Approaches 90%
- Test Specificity: 95-8%
- Combination screening
- Protocol: Invasive Testing to confirm chromosomal abnormalities
- Chorionic Villus Sampling (10-13 weeks)
- Amniocentesis (16-18 weeks)
- References
Prenatal Diagnosis (C0033053) | |
|---|---|
| Definition (MSH) | Determination of the nature of a pathological condition or disease in the postimplantation embryo, fetus, or pregnant female before birth. |
| Definition (CSP) | determination of the nature of a pathological condition or disease in the postimplantation embryo or fetus. |
| Concepts | Diagnostic Procedure (T060) |
| MSH | D011296 |
| English | ANTENATAL DIAG, Antenatal Diagnoses, Antenatal Diagnosis, antepartum diagnosis, DIAG ANTENATAL, DIAG INTRAUTERINE, DIAG PRENATAL, INTRAUTERINE DIAG, Intrauterine Diagnoses, Intrauterine Diagnosis, PRENATAL DIAG, Prenatal Diagnoses, Prenatal Diagnosis |
| Parent Concepts | system-specific diagnostic method (C0679561), Diagnosis (C0011900), Diagnostic Techniques, Obstetrical and Gynecological (C0011913) |
| Sources | AOD, CSP, LCH, MSH Derived from the NIH UMLS (Unified Medical Language System) |
